Login to Your Account

39 and counting . . . IPOs heating up again with Ardelyx latest to price

By Peter Winter
BioWorld Insight Editor

Friday, June 20, 2014
Any thoughts that initial public offerings (IPOs) for biotech companies have run out of steam will have to change those ideas. Wall Street is certainly warming up to biotech IPOs once again. Following this week's IPO pricing and strong market debut by ZS Pharma Inc., Fremont, Calif.-based Ardelyx Inc. followed suit, taking advantage of that renewed enthusiasm from investors and raised $60 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription